Doxazosin for the treatment of chronic congestive heart failure: Results of a randomized double-blind and placebo-controlled study
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (1) , 372-380
- https://doi.org/10.1016/0002-8703(91)90875-i
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Doxazosin Increases Low Density Lipoprotein Receptor ActivityActa Pharmacologica et Toxicologica, 2009
- Current therapy for heart failureThe American Journal of Medicine, 1988
- Pharmacokinetic overview of doxazosinThe American Journal of Cardiology, 1987
- Efficacy and safety of doxazosin in hypertension therapyThe American Journal of Cardiology, 1987
- Mechanism of alpha blockade for blood pressure controlThe American Journal of Cardiology, 1987
- Validation of a simple mechanical accelerometer (pedometer) for the estimation of walking activityEuropean Journal of Applied Physiology, 1987
- The antihypertensive effects of doxazosin: a clinical overview.British Journal of Clinical Pharmacology, 1986
- Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.Published by Wiley ,1986
- Clinical pharmacological studies with doxazosin.British Journal of Clinical Pharmacology, 1986
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977